Brenda Huneycutt is a director of FasterCures, a center of the Milken Institute. Prior to joining FasterCures, Huneycutt was vice president, regulatory strategy and FDA policy at Avalere Health, advising health-care clients on topics such as patient engagement in drug development, compassionate use/expanded access to investigational products, regulatory exclusivities, the Food and Drug Administration’s orphan drug and expedited programs, and the use of real-world evidence in regulatory decision-making. Huneycutt has also practiced as a patent lawyer and started out as a research scientist, primarily studying cell division and cell cycle control in yeast model systems. Huneycutt is a fellow with the Coalition for Epidemic Preparedness Innovations, working on challenges related to developing vaccines against diseases with epidemic potential. Huneycutt holds a PhD in molecular biology from the University of Colorado at Boulder, a JD from the George Washington University School of Law, and an MPH from the Johns Hopkins University Bloomberg School of Public Health.